Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Tendera

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
European Heart Journal|September 13, 2013
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisRonak Delewi, Alexander Hirsch, Jan G Tijssen, et al.
European Heart Journal|January 30, 2018
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathiesPhilippe Charron, Perry M Elliott, Juan R Gimeno, et al.
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
European Journal of Heart Failure|September 27, 2017
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trialAnthony Mathur, Roman Arnold, Birgit Assmus, et al.
Circulation Research|February 21, 2015
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient dataMariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, et al.
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
European Heart Journal|September 13, 2013
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisRonak Delewi, Alexander Hirsch, Jan G Tijssen, et al.
European Heart Journal|January 30, 2018
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathiesPhilippe Charron, Perry M Elliott, Juan R Gimeno, et al.
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Lancet (London, England)|March 23, 2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trialE Magnus Ohman, Matthew T Roe, P Gabriel Steg, et al.
European Journal of Heart Failure|September 27, 2017
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trialAnthony Mathur, Roman Arnold, Birgit Assmus, et al.
Circulation Research|February 21, 2015
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient dataMariann Gyöngyösi, Wojciech Wojakowski, Patricia Lemarchand, et al.
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
Pageof 14